Latest Insider Transactions at Cvs Health Corp (CVS)
This section provides a real-time view of insider transactions for Cvs Health Corp (CVS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CVS HEALTH Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CVS HEALTH Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2020
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
347
-3.43%
|
$20,473
$59.18 P/Share
|
|
Feb 28
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.01%
|
$59
$59.18 P/Share
|
|
Feb 28
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
SELL
Payment of exercise price or tax liability
|
Direct |
1,524
-3.2%
|
$89,916
$59.18 P/Share
|
|
Feb 28
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
BUY
Grant, award, or other acquisition
|
Direct |
3,379
+11.97%
|
$199,361
$59.18 P/Share
|
|
Feb 28
2020
|
Alan Lotvin EVP&President-PharmacyServices |
BUY
Grant, award, or other acquisition
|
Direct |
11,828
+29.74%
|
$697,852
$59.18 P/Share
|
|
Feb 28
2020
|
Alan Lotvin EVP&President-PharmacyServices |
SELL
Payment of exercise price or tax liability
|
Direct |
160
-1.89%
|
$9,440
$59.18 P/Share
|
|
Feb 28
2020
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
51,714
-9.38%
|
$3,051,126
$59.18 P/Share
|
|
Feb 28
2020
|
Larry J Merlo Director |
BUY
Grant, award, or other acquisition
|
Direct |
114,058
+17.15%
|
$6,729,422
$59.18 P/Share
|
|
Feb 28
2020
|
Thomas M Moriarty EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
13,457
-17.95%
|
$793,963
$59.18 P/Share
|
|
Feb 28
2020
|
Thomas M Moriarty EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
31,683
+29.71%
|
$1,869,297
$59.18 P/Share
|
|
Feb 28
2020
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,366
+17.66%
|
$3,738,594
$59.18 P/Share
|
|
Feb 28
2020
|
Derica W Rice EVP & President, CVS Caremark |
SELL
Payment of exercise price or tax liability
|
Direct |
8,079
-23.15%
|
$476,661
$59.18 P/Share
|
|
Feb 28
2020
|
Derica W Rice EVP & President, CVS Caremark |
BUY
Grant, award, or other acquisition
|
Direct |
21,943
+38.6%
|
$1,294,637
$59.18 P/Share
|
|
Feb 27
2020
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
SELL
Payment of exercise price or tax liability
|
Direct |
844
-3.98%
|
$49,796
$59.33 P/Share
|
|
Feb 18
2020
|
Karen S Lynch President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,215
-15.26%
|
-
|
|
Jan 15
2020
|
Larry J Merlo Director |
SELL
Open market or private sale
|
Direct |
266,476
-37.88%
|
$19,719,224
$74.79 P/Share
|
|
Jan 15
2020
|
Larry J Merlo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
314,713
+30.91%
|
$16,994,502
$54.53 P/Share
|
|
Jan 08
2020
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
57,563
-56.1%
|
$4,144,536
$72.63 P/Share
|
|
Jan 08
2020
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,844
+40.15%
|
$3,717,576
$54.53 P/Share
|
|
Dec 02
2019
|
Karen S Lynch President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,778
-18.25%
|
$958,350
$75.55 P/Share
|
|
Nov 20
2019
|
Mary L Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
775
+29.12%
|
$57,350
$74.92 P/Share
|
|
Nov 20
2019
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,551
+7.2%
|
$114,774
$74.92 P/Share
|
|
Nov 20
2019
|
Mark T Bertolini Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,551
+10.12%
|
$114,774
$74.92 P/Share
|
|
Nov 20
2019
|
Richard M Bracken Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,626
+9.58%
|
$120,324
$74.92 P/Share
|
|
Nov 20
2019
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,651
+1.41%
|
$122,174
$74.92 P/Share
|
|
Nov 20
2019
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,626
+9.05%
|
$120,324
$74.92 P/Share
|
|
Nov 20
2019
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,904
+2.88%
|
$288,896
$74.92 P/Share
|
|
Nov 20
2019
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,551
+50.0%
|
$114,774
$74.92 P/Share
|
|
Nov 20
2019
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,626
+12.55%
|
$120,324
$74.92 P/Share
|
|
Nov 20
2019
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,551
+50.0%
|
$114,774
$74.92 P/Share
|
|
Nov 20
2019
|
Richard J Swift Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,676
+18.6%
|
$124,024
$74.92 P/Share
|
|
Nov 20
2019
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,551
+4.73%
|
$114,774
$74.92 P/Share
|
|
Nov 18
2019
|
Karen S Lynch President and CEO |
SELL
Open market or private sale
|
Direct |
80,143
-65.71%
|
$6,010,725
$75.0 P/Share
|
|
Nov 04
2019
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
23,604
-21.87%
|
$1,605,072
$68.0 P/Share
|
|
Nov 04
2019
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,604
+17.95%
|
$1,274,616
$54.53 P/Share
|
|
Sep 30
2019
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
SELL
Open market or private sale
|
Direct |
17,703
-48.95%
|
$1,115,289
$63.0 P/Share
|
|
Sep 30
2019
|
Joshua Matthew Flum EVP, ENT STRATEGY & DIGITAL |
BUY
Exercise of conversion of derivative security
|
Direct |
17,703
+32.86%
|
$955,962
$54.53 P/Share
|
|
Sep 12
2019
|
Eva C Boratto EVP & CFO |
SELL
Open market or private sale
|
Direct |
8,130
-14.71%
|
$528,450
$65.0 P/Share
|
|
Sep 12
2019
|
Eva C Boratto EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,852
+13.8%
|
$478,008
$54.53 P/Share
|
|
May 31
2019
|
Derica W Rice EVP & President, CVS Caremark |
SELL
Payment of exercise price or tax liability
|
Direct |
3,576
-22.33%
|
$185,952
$52.37 P/Share
|
|
May 16
2019
|
Mary L Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,111
+50.0%
|
$57,772
$52.3 P/Share
|
|
May 16
2019
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+10.75%
|
$115,544
$52.3 P/Share
|
|
May 16
2019
|
Mark T Bertolini Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+15.38%
|
$115,544
$52.3 P/Share
|
|
May 16
2019
|
Richard M Bracken Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+14.52%
|
$121,160
$52.3 P/Share
|
|
May 16
2019
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,366
+2.04%
|
$123,032
$52.3 P/Share
|
|
May 16
2019
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+13.67%
|
$121,160
$52.3 P/Share
|
|
May 16
2019
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,592
+4.19%
|
$290,784
$52.3 P/Share
|
|
May 16
2019
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+50.0%
|
$115,544
$52.3 P/Share
|
|
May 16
2019
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+19.36%
|
$121,160
$52.3 P/Share
|
|
May 16
2019
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,222
+50.0%
|
$115,544
$52.3 P/Share
|